FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Company ProfileThe Cigna Group
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CI
The Cigna Group Stock AnalysisComprehensive stock analysis for The Cigna Group (CI) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCI
CI
The Cigna Group
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CI
Home🔹Stocks🔹The Cigna Group

The Cigna Group

🇺🇸CI•NYSE

The Cigna Group

🇺🇸CI•NYSE
Market cap
$80.80B
Sentiment

Your view on CI

Mkt Cap
$80.80B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About The Cigna Group

Industry
Medical - Healthcare Plans
Sector
Healthcare
CEO
David Michael Cordani
Headquarters
900 Cottage Grove Road, Bloomfield, CT, US
Industry
Medical - Healthcare Plans
Sector
Healthcare
CEO
David Michael Cordani
Headquarters
900 Cottage Grove Road, Bloomfield, CT, US
Description

The Cigna Group provides insurance and related products and services in the United States.

Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers.

The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations.

The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations.

It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for The Cigna Group, and the rating behind it. CI last traded at $305.78, 12.6× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for The Cigna Group. Starting points for The Cigna Group: P/E 12.6, EPS $24.31, beta 0.30 — an Medical - Healthcare Plans name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for The Cigna Group. The Cigna Group paid $6.19 per share over the last year — a 2.0% yield at the current $305.78 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for The Cigna Group. Trailing twelve-month EPS for The Cigna Group stands at $24.31. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for The Cigna Group. The Cigna Group has reported as a listed company since 1982. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

The Cigna Group valued side by side against its closest peers. The Cigna Group is measured against Medical - Healthcare Plans peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold The Cigna Group, and how their positions are changing. At a $80.80B market value, institutional positions materially move The Cigna Group's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by The Cigna Group executives and directors. Shares of The Cigna Group have traded between $239.51 and $350.00 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming The Cigna Group. The Cigna Group is a $80.80B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming The Cigna Group. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for The Cigna Group. Coverage tracks The Cigna Group within Medical - Healthcare Plans (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

Peer companies

  • ALHCAlignment Healthcare, Inc.
  • CNCCentene Corporation
  • CVSCVS Health Corporation
  • ELVElevance Health Inc.
  • HUMHumana Inc.
  • MOHMolina Healthcare, Inc.
  • OSCROscar Health, Inc.
  • UNHUnitedHealth Group Incorporated

More Medical - Healthcare Plans companies

  • UNH.NEUnitedHealth Group Inc
  • CLOVClover Health Investments, Corp.
  • IHGPJun An Kang Group Inc.
  • MRAIMarpai, Inc.

ETFs holding The Cigna Group

Largest holders, then the funds most concentrated in CI · % = share of the fund

  • VTIVanguard Total Stock Market ETF0.10%
  • VOOVanguard S&P 500 ETF0.11%
  • IVViShares Core SP 500 ETF0.12%
  • XSP.TOiShares Core S&P 500 Index ETF (CAD- Hedged)0.12%
  • IHFiShares US Healthcare Providers ETF4.66%
  • DUSADavis Select U.S. Equity ETF3.54%
  • FXHFirst Trust Health Care AlphaDEX Fund2.59%
  • RPVInvesco S&P 500 Pure Value ETF1.77%
CI Analysis
Good
Past2
Growth5
Health3
Profit3
Value3

News

Latest Market News

No comments yet

Be the first to ask a question or say what you make of The Cigna Group.